Table 2.
Antimicrobial resistance profiles of hospital-acquired bacterial isolates from clinical urine specimens.
| Antimicrobial agents | Microorganisms | Total n (%) | ||||||
|---|---|---|---|---|---|---|---|---|
| CoNS* n (%) |
E. coli
n (%) |
P. vulgaris
n (%) |
Enterococcus sp. n (%) |
En
te
ro
ba
c
te
r sp. n (%) |
S. aureus
n (%) |
P. aeruginosa
n (%) |
||
| Ciprofloxacin | 20 (57.1) | 80 (40) | 10 (50) | 7 (46.6) | 2 (40) | 3 (15) | 3 (60) | 125 (41.6) |
| Ceftazidime | 15 (42.8) | 18 (9) | 8 (40) | 4 (26.6) | 1 (20) | 4 (20) | 3 (60) | 53 (17.7) |
| Amikacin | 22 (62.8) | 5 (2.5) | 7 (35) | 6 (40) | 1 (20) | 5 (25) | 3 (60) | 49 (16.3) |
| Imipenem | 10 (28.5) | 5 (2.5) | 4 (20) | 2 (13.3) | 0 (0) | 5 (25) | 2 (40) | 28 (9.3) |
| Clindamycin | 20 (57.1) | 19 (9.5) | 4 (20) | 8 (53.3) | 1 (20) | 6 (30) | 3 (60) | 61 (20.3) |
| Nalidixic acid | 7 (20) | 115 (57.7) | 7 (35) | 7 (46.6) | 1 (20) | 6 (30) | 4 (80) | 147 (49) |
| Cephalothin | 18 (51.4) | 20 (10) | 8 (40) | 10 (66.6) | 1 (20) | 6 (30) | 4 (80) | 67 (22.3) |
| Ampicillin | 34 (97.1) | 80 (40) | 14 (70) | 12 (80) | 2 (40) | 18 (90) | 5 (100) | 165 (55) |
| Cotrimoxazole | 20 (57.1) | 100 (50) | 10 (50) | 10 (66.6) | 1 (20) | 10 (50) | 3 (60) | 154 (51.3) |
| Nitrofurantoin | 28 (80) | 80 (40) | 13 (65) | 7 (46.6) | 2 (40) | 8 (40) | 3 (60) | 141 (47) |
| Erythromycin | 15 (42.8) | 43 (21.5) | 7 (35) | 4 (26.6) | 1 (20) | 12 (60) | 2 (40) | 84 (28) |
| Tetracycline | 25 (71.4) | 24 (12) | 3 (15) | 5 (33.3) | 1 (20) | 10 (50) | 3 (60) | 71 (23.7) |
| Penicillin | 35 (100) | 55 (27.5) | 12 (60) | 13 (86.6) | 3 (60) | 18 (90) | 5 (100) | 141 (47) |
| Gentamicin | 10 (28.5) | 10 (5) | 6 (30) | 9 (60) | 2 (40) | 9 (45) | 2 (40) | 48 (16) |
|
| ||||||||
| Total | 35 (11.7) | 200 (66.7) | 20 (6.7) | 15 (5) | 5 (1.7) | 20 (6.7) | 5 (1.7) | 300 (100) |
CoNS*: Coagulase-negative Staphylococci.